Study of Thymosin Beta 4 in Patients With Venous Stasis Ulcers
Clinical trial NCT00832091 · COMPLETED
Trial details
- NCT number
- NCT00832091
- Sponsor
- RegeneRx Biopharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-07-01
- Primary completion
- 2009-01-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.